NDC 0404-9925

NEOSTIGMINE METHYLSULFATE

Neostigmine Methylsulfate

NEOSTIGMINE METHYLSULFATE is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Henry Schein, Inc.. The primary component is Neostigmine Methylsulfate.

Product ID0404-9925_9c788ae9-4120-4248-a192-307b0b57a65c
NDC0404-9925
Product TypeHuman Prescription Drug
Proprietary NameNEOSTIGMINE METHYLSULFATE
Generic NameNeostigmine Methylsulfate
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-01-13
Marketing CategoryANDA /
Application NumberANDA209933
Labeler NameHenry Schein, Inc.
Substance NameNEOSTIGMINE METHYLSULFATE
Active Ingredient Strength1 mg/mL
Pharm ClassesCholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0404-9925-10

1 VIAL, MULTI-DOSE in 1 BAG (0404-9925-10) > 10 mL in 1 VIAL, MULTI-DOSE
Marketing Start Date2022-01-13
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "NEOSTIGMINE METHYLSULFATE" or generic name "Neostigmine Methylsulfate"

NDCBrand NameGeneric Name
0404-9925NEOSTIGMINE METHYLSULFATEneostigmine methylsulfate
0517-1133Neostigmine MethylsulfateNeostigmine Methylsulfate
0517-1134Neostigmine MethylsulfateNeostigmine Methylsulfate
0548-9601NEOSTIGMINE METHYLSULFATEneostigmine methylsulfate
0548-9602NEOSTIGMINE METHYLSULFATEneostigmine methylsulfate
0641-6149Neostigmine MethylsulfateNeostigmine Methylsulfate
0641-6150Neostigmine MethylsulfateNeostigmine Methylsulfate
14445-413NEOSTIGMINE METHYLSULFATENEOSTIGMINE METHYLSULFATE
14445-414NEOSTIGMINE METHYLSULFATENEOSTIGMINE METHYLSULFATE
25021-610Neostigmine MethylsulfateNeostigmine Methylsulfate
25021-611Neostigmine MethylsulfateNeostigmine Methylsulfate
31722-994neostigmine methylsulfateneostigmine methylsulfate
31722-995neostigmine methylsulfateneostigmine methylsulfate
42023-188NEOSTIGMINE METHYLSULFATENEOSTIGMINE METHYLSULFATE
42023-189NEOSTIGMINE METHYLSULFATENEOSTIGMINE METHYLSULFATE
50090-4532NEOSTIGMINE METHYLSULFATEneostigmine methylsulfate
50090-5197Neostigmine methylsulfateNeostigmine methylsulfate
51662-1557NEOSTIGMINE METHYLSULFATENEOSTIGMINE METHYLSULFATE
52584-057NEOSTIGMINE METHYLSULFATEneostigmine methylsulfate
52584-415Neostigmine MethylsulfateNeostigmine Methylsulfate
63323-413Neostigmine MethylsulfateNeostigmine Methylsulfate
63323-415Neostigmine MethylsulfateNeostigmine Methylsulfate
70121-1479Neostigmine methylsulfateNeostigmine methylsulfate
70121-1478Neostigmine methylsulfateNeostigmine methylsulfate
71872-7016NEOSTIGMINE METHYLSULFATENEOSTIGMINE METHYLSULFATE
71872-7143NEOSTIGMINE METHYLSULFATENEOSTIGMINE METHYLSULFATE
76045-383Neostigmine MethylsulfateNeostigmine Methylsulfate
71839-105Neostigmine methylsulfateNeostigmine methylsulfate
71839-106Neostigmine methylsulfateNeostigmine methylsulfate
68083-383Neostigmine methylsulfateNeostigmine methylsulfate
68083-384Neostigmine methylsulfateNeostigmine methylsulfate
72572-460neostigmine methylsulfateneostigmine methylsulfate
72572-461neostigmine methylsulfateneostigmine methylsulfate
72572-462Neostigmine MethylsulfateNeostigmine Methylsulfate
70700-172Neostigmine methylsulfateNeostigmine methylsulfate
51754-1210BloxiverzNeostigmine Methylsulfate
51754-1220BloxiverzNeostigmine Methylsulfate
51754-1240Bloxiverzneostigmine methylsulfate

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.